Figure 1 : Showing different scores for the immunohistochemical stain intensity: A (negative stain), B (weak stain intensity), C (moderate stain intensity), D (strong stain intensity), E (very strong stain intensity).

Aliskiren treated group was associated with a median stain intensity of moderate for VCAM-1 (C) and weak for MCP-1, IL-17 and TNF-alpha (B).

A Al-Aubaidy et al.Journal of Pharmaceutical Technology and Drug Research  2013 2:11DOI : 10.7243/2050-120X-2-11